Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients - PubMed (original) (raw)

Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients

Seyed Mohammadreza Bitaraf et al. Asian Pac J Cancer Prev. 2018.

Abstract

Objective: CD44 is an important cell adhesion molecule that plays a key role in growth, invasion, proliferation and metastasis of cancer cells. CD44 protein over-expression is associated with a poor prognosis of gastric cancer (GC) and previous studies have shown that CD44 gene polymorphisms could affect survival and recurrence. In this study, we tested the hypothesis that polymorphisms impacting on the CD44 signaling pathway may predict clinical outcomes in patients with GC. Materials and Methods: DNA was extracted from blood of 150 healthy individuals and formalin-fixed paraffin-embedded (FFPE) tumor tissue of 150 patients. The two polymorphisms rs187116 and rs7116432 were studied by RFLP-PCR and sequencing techniques. Results: There was a strong significant correlation between single nucleotide polymorphisms (SNPs) in the CD44 gene, tumor recurrence, and overall survival (p <0.0001). The existence of a significant relationship between tumor recurrence and overall survival was proved in this study, with at least one allele G for the polymorphism rs187116 and at least one allele A for polymorphism rs7116432. Conclusion: These results provide evidence of a relationship between CD44 gene polymorphisms and clinical outcomes in our GC patients. This result could help identify individuals with GC who have a high risk of tumor recurrence.

Keywords: Gastric cancer; CD44 gene; single nucleotide polymorphism; RFLP-PCR.

Creative Commons Attribution License

PubMed Disclaimer

References

    1. Barbour AP, Reeder JA, Walsh MD, et al. Expression of the CD44v2-10 isoform confers a metastatic phenotype:importance of the heparan sulfate attachment site CD44v3. Cancer Res. 2003;63:887–92. - PubMed
    1. Bourguignon LY, Zhu H, Chu A, et al. Interaction between the adhesion receptor, CD44, and the oncogene product, p185 HER2, promotes human ovarian tumor cell activation. J Biol Chem. 1997;272:27913–8. - PubMed
    1. Bourguignon LY, Zhu H, Shao L, et al. Rho-kinase (ROK) promotes CD44v3, 8–10-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cytoskeleton. 1999;43:269–87. - PubMed
    1. D'angelica M, Gonen M, Brennan MF, et al. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240:808. - PMC - PubMed
    1. Ghaffarzadehgan K, Jafarzadeh M, Raziee HR, et al. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance. W J Gastroenterol. 2008;14:6376. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources